FUNDC2 and cancer: The data exhibited that mutation of Serine 167 in FUNDC2 to Lysine (Lys or K) or Proline (Pro or P) showed pathogenicity rates of 0.587 and 0.747, respectively (Fig 7B), indicating that this site indeed plays a key role and also consistent with the clinical observations in cancer patients (Fig 6).